
The latest COVID-19 data on confirmed cases, recoveries, and more from the Johns Hopkins COVID-19 interactive map.

The latest COVID-19 data on confirmed cases, recoveries, and more from the Johns Hopkins COVID-19 interactive map.
New data from the Diabetes Prevention Outcomes Study shows persistent reduction of type 2 diabetes development over 22-year average follow-up.

Physicians’ CKD awareness in T2D is linked with CKD severity, suggests a new study presented this week at the American Diabetes Association’s 80th Virtual Scientific Sessions.

New research from the University of Oxford found dexamethasone reduced death by one-third in severely ill patients hospitalized with COVID-19.
VIDEO: Silvio Inzucchi, MD, discusses results of a prespecified analysis of the DAPA-HF trial, which found that dapagliflozin reduced new onset diabetes by 32% in patients with heart failure.

The FDA revoked the emergency use authorization that allowed the malaria drug to be used to treat hospitalized patients with COVID-19.

There are now >8 million confirmed cases of COVID-19 globally. Plus more data from the Johns Hopkins COVID-19 interactive map you should know about today.

ADA 2020: Glycemic control was worse for black patients who experienced hurried interaction with healthcare providers than for those who did not, a new study reports.

ADA 2020. Improvement in glycemic control among US veterans was seen across 5 study sites and was sustained at 18 months after study initiation, says study reported at the ADA 80th Virtual Scientific Sessions.

ADA 2020. An investigational once-weekly insulin proved comparable in safety and efficacy to traditional once-daily insulin glargine in findings presented at the ADA 80th Annual Virtual Scientific Sessions.

As many US states reopen their economies, 22 states have seen a surge in new cases of COVID-19.

ADA 2020. Dapagliflozin reduced new onset type 2 diabetes in patients with heart failure with reduced ejection fraction, according to a study released today at the ADA 80th Virtual Scientific Sessions.

ADA2020: Empagliflozin significantly, durably delays need for insulin and for large dose increases, in patients with type 2 diabetes and cardiovascular disease, finds study presented at ADA 80th Scientific Sessions.

ADA 2020: A new automatic insulin delivery system improves glycemic control in young people with type 1 diabetes, according to research presented at the American Diabetes Association Virtual Scientific Sessions.

Taking blood pressure medication as prescribed may help even the frailest elderly patients live longer, according to a new study.

Get the latest data on confirmed cases, recoveries, and more with our daily COVID-19 update.

The New York Times asked 511 epidemiologists when they might resume hair cuts, shaking hands, air travel, bus rides, and 15 other "normal" activities suspended during COVID-19 social distancing.

Over 2 million cases of COVID-19 have been confirmed in the US, with 14 states recording their highest 7-day average of new COVID-19 infections.

A new survey reports that 83% of patients would be distressed if they lost this trusted relationship. As COVID-19 cases surge and practices close, patients are uneasy about even more.

A recent review examined how well family practice and emergency department physicians follow recommended guidelines on managing low back pain. See what they found with these 10 questions.